Journal Article DZNE-2020-05456

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Encapsulation of two different TLR ligands into liposomes confer protective immunity and prevent tumor development.

 ;  ;  ;  ;  ;

2017
Elsevier New York, NY [u.a.]

Journal of controlled release 247, 134-144 () [10.1016/j.jconrel.2017.01.004]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: Nucleic acid-based Toll-like receptor (TLR) ligands are promising adjuvants and immunotherapeutic agents. Combination of TLR ligands potentiates immune response by providing synergistic immune activity via triggering different signaling pathways and may impact antigen dependent T-cell immune memory. However, their short circulation time due to nuclease attack hampers their clinical performance. Liposomes offer inclusion of protein and nucleic acid-based drugs with high encapsulation efficiency and drug loading. Furthermore, they protect cargo from enzymatic cleavage while providing stability, and enhancing biological activity. Herein, we aimed to develop a liposomal carrier system co-encapsulating TLR3 (polyinosinic-polycytidylic acid; poly(I:C)) and TLR9 (oligodeoxynucleotides (ODN) expressing unmethylated CpG motifs; CpG ODN) ligands as immunoadjuvants together with protein antigen. To demonstrate that this depot system not only induce synergistic innate immune activation but also boost antigen-dependent immune response, we analyzed the potency of dual ligand encapsulated liposomes in long-term cancer protection assay. Data revealed that CpG ODN and poly(I:C) co-encapsulation significantly enhanced cytokine production from spleen cells. Activation and maturation of dendritic cells as well as bactericidal potency of macrophages along with internalization capacity of ligands were elevated upon incubation with liposomes co-encapsulating CpG ODN and poly(I:C). Immunization with co-encapsulated liposomes induced OVA-specific Th1-biased immunity which persisted for eight months post-booster injection. Subsequent challenge with OVA-expressing tumor cell line, E.G7, demonstrated that mice immunized with liposomes co-encapsulating dual ligands had significantly slower tumor progression. Tumor clearance was dependent on OVA-specific cytotoxic memory T-cells. These results suggest that liposomes co-encapsulating TLR3 and TLR9 ligands and a specific cancer antigen could be developed as a preventive cancer vaccine.

Keyword(s): Adjuvants, Immunologic: administration & dosage (MeSH) ; Adjuvants, Immunologic: pharmacology (MeSH) ; Adjuvants, Immunologic: therapeutic use (MeSH) ; Animals (MeSH) ; Cancer Vaccines: administration & dosage (MeSH) ; Cancer Vaccines: pharmacology (MeSH) ; Cancer Vaccines: therapeutic use (MeSH) ; Female (MeSH) ; Immunity: drug effects (MeSH) ; Immunization (MeSH) ; Interferons: immunology (MeSH) ; Interleukin-6: immunology (MeSH) ; Liposomes: chemistry (MeSH) ; Mice (MeSH) ; Mice, Inbred C57BL (MeSH) ; Neoplasms: immunology (MeSH) ; Neoplasms: prevention & control (MeSH) ; Oligodeoxyribonucleotides: administration & dosage (MeSH) ; Oligodeoxyribonucleotides: pharmacology (MeSH) ; Oligodeoxyribonucleotides: therapeutic use (MeSH) ; Poly I-C: administration & dosage (MeSH) ; Poly I-C: pharmacology (MeSH) ; Poly I-C: therapeutic use (MeSH) ; RAW 264.7 Cells (MeSH) ; Toll-Like Receptor 3: immunology (MeSH) ; Toll-Like Receptor 9: immunology (MeSH) ; Adjuvants, Immunologic ; CPG-oligonucleotide ; Cancer Vaccines ; Interleukin-6 ; Liposomes ; Oligodeoxyribonucleotides ; Toll-Like Receptor 3 ; Toll-Like Receptor 9 ; Interferons ; Poly I-C

Classification:

Contributing Institute(s):
  1. Dresden common (Dresden common)
Research Program(s):
  1. 342 - Disease Mechanisms and Model Systems (POF3-342) (POF3-342)

Appears in the scientific report 2017
Database coverage:
Medline ; BIOSIS Previews ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; Ebsco Academic Search ; IF >= 10 ; JCR ; NationallizenzNationallizenz ; SCOPUS ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > DD DZNE > DD DZNE-Dresden common
Public records
Publications Database

 Record created 2020-02-18, last modified 2024-03-21


Fulltext:
Download fulltext PDF Download fulltext PDF (PDFA)
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)